AFT Pharmaceuticals (NZE:AFT, ASX:AFP) expects to incur an operating loss of below NZ$2 million for the six months ended Sept. 30, according to a Friday filing with the New Zealand bourse.
The pharmaceuticals company attributed the first-half loss to lower sales amid a reduction in orders from large customers and a doctors' strike in South Korea, among other factors.
AFT will report its interim results on Nov. 21.
The company's shares were down more than 8% in recent trade.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。